Nutrition Research and Practice

  • 제16권4호
  • /
  • Pages.435-449
  • /
  • 2022
  • /
  • 1976-1457(pISSN)
  • /
  • 2005-6168(eISSN)
한국영양학회 (The Korean Nutrition Society)
권호 표지
DOI QR코드

DOI QR Code

Comparison of laxative effects of fermented soybeans (Cheonggukjang) containing toxins and biogenic amines against loperamide-induced constipation mouse model

  • 투고 : 2021.07.12
  • 심사 : 2021.10.29
  • 발행 : 2022.08.01
PDF 다운로드
⟨ 이전 논문 다음 논문 ⟩

초록

BACKGROUND/OBJECTIVES: Cheonggukjang is a traditional fermented soybean paste with significant health-promoting effects. On the other hand, there have been insufficient studies on the safety and efficacy of Cheonggukjang, which is produced using traditional methods containing toxins and biogenic amines (BAs). This study compared the laxative effect of Cheonggukjang, containing high or low levels of toxins and BAs (HTBC or LTBC) in a loperamide (Lop)-induced constipation mouse model. MATERIALS/METHODS: To induce constipation, Lop (5 mg/kg) was administered orally to ICR mice twice a day for 4 days, and the dose was increased to 8 mg/kg after a 3-day rest period. Cheonggukjang (500 mg/kg, HTBC, or LTBC respectively) was administered for four weeks before the Lop treatment. RESULTS: The number of stools, fecal weight, water contents, gastrointestinal transit, and histological alterations were recovered significantly in the HTBC or LTBC groups. HTBC and LTBC administration did not induce significant changes in body weight, dietary intake, and behavior. The opioid-receptor downstream signaling pathway in colon tissues was also evaluated. The c-Kit, stem cell kinase, and mitogen-activated protein kinases subfamilies, including extracellular signal-regulated kinase 1/2, c-Jun N-terminal kinases, and p38, were all downregulated in the HTBC or LTBC-administered mice colon compared to the Lop group. CONCLUSION: These results show that Cheonggukjang, containing high levels of toxins and BAs, have a similar laxative effect in a mouse model of Lop-induced constipation.

키워드

과제정보

This research was funded by "Traditional food safety monitoring program" under the Ministry of Agriculture, Food and Rural Affairs and partly Korea Agro-Fisheries and Food trade corporation in 2020.

참고문헌

  1. Woo JK, Choi S, Kang JH, Kim DE, Hurh BS, Jeon JE, Kim SY, Oh SH. Fermented barley and soybean (BS) mixture enhances intestinal barrier function in dextran sulfate sodium (DSS)-induced colitis mouse model. BMC Complement Altern Med 2016;16:498. https://doi.org/10.1186/s12906-016-1479-0
  2. Chen L, Zhang J, Suo H, Wang W, Wang H, Zhang Y, Hu Q, Zhao X, Li J. Preventive effects of different fermentation times of Shuidouchi on diphenoxylate-induced constipation in mice. Foods 2019;8:86. https://doi.org/10.3390/foods8030086
  3. Park YK, Lee JH, Mah JH. Occurrence and reduction of biogenic amines in traditional Asian fermented soybean foods: a review. Food Chem 2019;278:1-9. https://doi.org/10.1016/j.foodchem.2018.11.045
  4. ten Brink B, Damink C, Joosten HM, Huis in 't Veld JH. Occurrence and formation of biologically active amines in foods. Int J Food Microbiol 1990;11:73-84. https://doi.org/10.1016/0168-1605(90)90040-C
  5. Mah JH, Park YK, Jin YH, Lee JH, Hwang HJ. Bacterial production and control of biogenic amines in Asian fermented soybean foods. Foods 2019;8:85. https://doi.org/10.3390/foods8020085
  6. Silla Santos MH. Biogenic amines: their importance in foods. Int J Food Microbiol 1996;29:213-31. https://doi.org/10.1016/0168-1605(95)00032-1
  7. Jeon AR, Lee JH, Mah JH. Biogenic amine formation and bacterial contribution in Cheonggukjang, a Korean traditional fermented soybean food. Lebensm Wiss Technol 2018;92:282-9. https://doi.org/10.1016/j.lwt.2018.02.047
  8. Ibe A, Nishima T, Kasai N. Bacteriological properties of and amine-production conditions for tyramine-and histamine-producing bacterial strains isolated from soybean paste (miso) starting materials. Eisei kagaku 1992;38:403-9. https://doi.org/10.1248/jhs1956.38.403
  9. Lee YJ, Kim JE, Kwak MH, Go J, Son HJ, Kim DS, Kang BC, Lee HS, Hwang DY. Toxicity of fermented soybean product (Cheonggukjang) manufactured by mixed culture of Bacillus subtilis MC31 and Lactobacillus sakei 383 on liver and kidney of ICR mice. Lab Anim Res 2014;30:54-63. https://doi.org/10.5625/lar.2014.30.2.54
  10. Shin D, Jeong D. Korean traditional fermented soybean products: Jang. J Ethn Foods 2015;2:2-7. https://doi.org/10.1016/j.jef.2015.02.002
  11. Camilleri M, Ford AC, Mawe GM, Dinning PG, Rao SS, Chey WD, Simren M, Lembo A, Young-Fadok TM, Chang L. Chronic constipation. Nat Rev Dis Primers 2017;3:17095. https://doi.org/10.1038/nrdp.2017.95
  12. Garcia-Garcia P, Brenes-Balbuena M, Hornero-Mendez D, Garcia-Borrego A, Garrido-Fernandez A. Content of biogenic amines in table olives. J Food Prot 2000;63:111-6. https://doi.org/10.4315/0362-028X-63.1.111
  13. Kim JE, Yun WB, Sung JE, Lee HA, Choi JY, Choi YS, Jung YS, Kim KS, Hwang DY. Characterization the response of Korl:ICR mice to loperamide induced constipation. Lab Anim Res 2016;32:231-40. https://doi.org/10.5625/lar.2016.32.4.231
  14. Su H, Chen J, Miao S, Deng K, Liu J, Zeng S, Zheng B, Lu X. Lotus seed oligosaccharides at various dosages with prebiotic activity regulate gut microbiota and relieve constipation in mice. Food Chem Toxicol 2019;134:110838. https://doi.org/10.1016/j.fct.2019.110838
  15. Tan YY, Ji ZL, Zhao G, Jiang JR, Wang D, Wang JM. Decreased SCF/c-kit signaling pathway contributes to loss of interstitial cells of Cajal in gallstone disease. Int J Clin Exp Med 2014;7:4099-106.
  16. Ro S, Park C, Jin J, Zheng H, Blair PJ, Redelman D, Ward SM, Yan W, Sanders KM. A model to study the phenotypic changes of interstitial cells of Cajal in gastrointestinal diseases. Gastroenterology 2010;138:1068-1078.e1-2. https://doi.org/10.1053/j.gastro.2009.11.007
  17. Ihara E, Akiho H, Nakamura K, Turner SR, Macdonald JA. MAPKs represent novel therapeutic targets for gastrointestinal motility disorders. World J Gastrointest Pathophysiol 2011;2:19-25. https://doi.org/10.4291/wjgp.v2.i2.19
  18. Kwon DY, Chung KR, Jang DJ. The history and science of Chongkukjang, a Korean fermented soybean product. J Ethn Foods 2019;6:5. https://doi.org/10.1186/s42779-019-0004-8
  19. Park KY, Kim JY, Moon SH. Anti-obesity and anti- inflammatory effects of Cheonggukjang. FASEB J 2011;25:584.8.
  20. Choi JH, Pichiah PB, Kim MJ, Cha YS. Cheonggukjang, a soybean paste fermented with B. licheniformis-67 prevents weight gain and improves glycemic control in high fat diet induced obese mice. J Clin Biochem Nutr 2016;59:31-8. https://doi.org/10.3164/jcbn.15-30
  21. Soh J, Kwon DY, Cha YS. Hepatic gene expression profiles are altered by dietary unsalted Korean fermented soybean (Chongkukjang) consumption in mice with diet-induced obesity. J Nutr Metab 2011;2011:260214. https://doi.org/10.1155/2011/260214
  22. Oh SJ, Mah JH, Kim JH, Kim YW, Hwang HJ. Reduction of tyramine by addition of Schizandra chinensis baillon in Cheonggukjang. J Med Food 2012;15:1109-15. https://doi.org/10.1089/jmf.2012.2561
  23. Locke GR 3rd, Pemberton JH, Phillips SF; American Gastroenterological Association. AGA technical review on constipation. Gastroenterology 2000;119:1766-78. https://doi.org/10.1053/gast.2000.20392
  24. Shimotoyodome A, Meguro S, Hase T, Tokimitsu I, Sakata T. Decreased colonic mucus in rats with loperamide-induced constipation. Comp Biochem Physiol A Mol Integr Physiol 2000;126:203-12. https://doi.org/10.1016/S1095-6433(00)00194-X
  25. Wong BS, Manabe N, Camilleri M. Role of prucalopride, a serotonin (5-HT4) receptor agonist, for the treatment of chronic constipation. Clin Exp Gastroenterol 2010;3:49-56.
  26. Sanders KM, Koh SD, Ward SM. Interstitial cells of Cajal as pacemakers in the gastrointestinal tract. Annu Rev Physiol 2006;68:307-43. https://doi.org/10.1146/annurev.physiol.68.040504.094718
  27. Li F, Zhou H, Zhou X, Yi R, Mu J, Zhao X, Liu W. Lactobacillus plantarum CQPC05 isolated from pickled vegetables inhibits constipation in mice. Applied Sciences 2019;9:159. https://doi.org/10.3390/app9010159
  28. Nelson AD, Camilleri M. Chronic opioid induced constipation in patients with nonmalignant pain: challenges and opportunities. Therap Adv Gastroenterol 2015;8:206-20. https://doi.org/10.1177/1756283X15578608
  29. Pearson G, Robinson F, Beers Gibson T, Xu BE, Karandikar M, Berman K, Cobb MH. Mitogen-activated protein (MAP) kinase pathways: regulation and physiological functions. Endocr Rev 2001;22:153-83. https://doi.org/10.1210/er.22.2.153
  30. Al-Hasani R, Bruchas MR. Molecular mechanisms of opioid receptor-dependent signaling and behavior. Anesthesiology 2011;115:1363-81. https://doi.org/10.1097/aln.0b013e318238bba6
  31. Yang D, Zhou Q, Labroska V, Qin S, Darbalaei S, Wu Y, Yuliantie E, Xie L, Tao H, Cheng J, et al. G protein-coupled receptors: structure- and function-based drug discovery. Signal Transduct Target Ther 2021;6:7. https://doi.org/10.1038/s41392-020-00435-w